YCS-19191-58646

2 vaccinations 9 coded responses 25 check-ins 9 free-text entries 0 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 717 / AR
Registered: 2021-10-22

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Registered dependents

VGS-15845-85029 Child or adolescent in my care · Male · 2022-02-26

2XF-20516-87411 Child or adolescent in my care · Male · 2022-02-26

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-10-22
Registered in v-safe
2021-10-22
Dose 1 — Pfizer-BioNTech
2021-10-22
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-23
Health check-in — days 1–6 daily, dose 1
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-24
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-25
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-10-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-10-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-10-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-10-29
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-11-05
Survey response — day 14, dose 1
MedDRA: Alopecia, Decreased appetite, Diarrhoea, Parosmia, Taste disorder — Feeling: Fair

Free text: Loss of appetite, hair loss, diarrhea, and altered sense of smell and taste.

MedDRA releases: 2024-11 · check-in free text available
2021-11-12
Dose 2 — Pfizer-BioNTech
2021-11-12
Survey response — day 0, dose 2
MedDRA: Dyspnoea, Hyperhidrosis — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Joint pains, Fatigue or tiredness

Free text: Profuse sweating and shortness of breath

MedDRA releases: 2024-11 · check-in free text available
2021-11-13
Survey response — days 1–6 daily, dose 2
MedDRA: Hyperhidrosis — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Profuse sweating

MedDRA releases: 2024-11 · check-in free text available
2021-11-14
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-11-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-11-16
Survey response — days 1–6 daily, dose 2
MedDRA: Decreased appetite, Hyperhidrosis — Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Loss of appetite and sweating

MedDRA releases: 2024-11 · check-in free text available
2021-11-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Headache, Joint pains, Fatigue or tiredness, Nausea, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-11-18
Survey response — days 1–6 daily, dose 2
MedDRA: Chest pain, Dyspnoea — Feeling: Fair · Fever · Joint pains, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Free text: Chest pains and shortness of breath

MedDRA releases: 2024-11 · check-in free text available
2021-11-19
Health check-in — day 7, dose 2
Feeling: Fair · Fever · Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Adult check-in
2021-11-26
Survey response — day 14, dose 2
MedDRA: Alopecia, Decreased appetite, Dizziness, Ear pain, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities

Free text: Significant hair shedding/loss, loss of appetite, dizziness, ear pain, fever

MedDRA releases: 2024-11 · check-in free text available
2021-12-03
Survey response — day 21, dose 2
MedDRA: Abdominal pain upper, Headache, Nasal congestion, Oropharyngeal pain, Rash, Rash pruritic — Feeling: Fair · Be unable to do your normal daily activities

Free text: Itchy rash all over my body, headache, stomach cramps, nasal congestion, and sore throat

MedDRA releases: 2024-11 · check-in free text available
2021-12-10
Survey response — day 28, dose 2
MedDRA: Dizziness, Fatigue, Headache, Rash, Rash pruritic — Feeling: Fair · Be unable to do your normal daily activities

Free text: Itching rash on my body, headaches, fatigue, dizziness,

MedDRA releases: 2024-11 · check-in free text available
2021-12-17
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-12-24
Survey response — day 42, dose 2
MedDRA: Cough, Dizziness, Ear pain, Fatigue, Headache, Nausea, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Nausea, headache, fatigue, dizziness, ear pain, congestion, and cough

MedDRA releases: 2024-11 · check-in free text available
2022-02-11
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-05-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-11-12
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-10-22	Pfizer-BioNTech	No
2	2021-11-12	Pfizer-BioNTech	No

Free text

Release 10 — day 14, dose 1

2021-11-05

Symptoms: Loss of appetite, hair loss, diarrhea, and altered sense of smell and taste.

Release 10 — day 0, dose 2

2021-11-12

Systemic reaction (other): Profuse sweating and shortness of breath

Release 10 — days 1–6 daily, dose 2

2021-11-13

Systemic reaction (other): Profuse sweating

2021-11-16

Systemic reaction (other): Loss of appetite and sweating

2021-11-18

Systemic reaction (other): Chest pains and shortness of breath

Release 10 — day 14, dose 2

2021-11-26

Symptoms: Significant hair shedding/loss, loss of appetite, dizziness, ear pain, fever

Release 10 — day 21, dose 2

2021-12-03

Symptoms: Itchy rash all over my body, headache, stomach cramps, nasal congestion, and sore throat

Release 10 — day 28, dose 2

2021-12-10

Symptoms: Itching rash on my body, headaches, fatigue, dizziness,

Release 10 — day 42, dose 2

2021-12-24

Symptoms: Nausea, headache, fatigue, dizziness, ear pain, congestion, and cough

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain upper	·	·	✓
SD	Alopecia	·	·	✓
SD	Cough	·	·	✓
SD	Decreased appetite	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Dizziness	·	·	✓
SD	Ear pain	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Nausea	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Parosmia	·	·	✓
SD	Pyrexia	·	·	✓
SD	Rash	·	·	✓
SD	Rash pruritic	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Taste disorder	·	·	✓
SRO	Chest pain	·	·	✓
SRO	Decreased appetite	·	·	✓
SRO	Dyspnoea	·	·	✓
SRO	Hyperhidrosis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release